<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32505190</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1742-2094</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>06</Day></PubDate></JournalIssue><Title>Journal of neuroinflammation</Title><ISOAbbreviation>J Neuroinflammation</ISOAbbreviation></Journal><ArticleTitle>Disease propagation in amyotrophic lateral sclerosis (ALS): an interplay between genetics and environment.</ArticleTitle><Pagination><StartPage>175</StartPage><MedlinePgn>175</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">175</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12974-020-01849-7</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive, fatal disease affecting the neuromuscular system. While there have been a number of important genetic discoveries, there are no therapeutics capable of stopping its insidious progression. Lessons from clinical histories reveal that ALS can start focally at a single limb, but then segmentally spread up and down the spinal cord as well as in the motor cortex and cortex of frontal and temporal lobes until respiratory muscles fail. With or without a clear genetic etiology, often there is no explanation as to why it starts in one region of the body versus another. Similarly, once the disease starts the mechanisms by which the neurodegenerative process spreads are not known. Here, we summarize recent work in animal models that support the hypothesis that critical environmental contributions, such as a nerve injury, can initiate the disease process. We also propose that pathological axoglial signaling by the glial growth factor neuregulin-1 leads to the slow propagation of neuroinflammation resulting in neurodegeneration up and down the spinal cord and that locally applied drugs that block neuregulin-1 signaling could slow or halt the spread of disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schram</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology and Rehabilitation, University of Illinois at Chicago, NPI North Bldg., Room 657, M/C 796, 912 S. Wood Street, Chicago, IL, 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loeb</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Neurology and Rehabilitation, University of Illinois at Chicago, NPI North Bldg., Room 657, M/C 796, 912 S. Wood Street, Chicago, IL, 60612, USA. jaloeb@uic.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Fei</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-1705-1686</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Rehabilitation, University of Illinois at Chicago, NPI North Bldg., Room 657, M/C 796, 912 S. Wood Street, Chicago, IL, 60612, USA. feisong@uic.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neuroinflammation</MedlineTA><NlmUniqueID>101222974</NlmUniqueID><ISSNLinking>1742-2094</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059647" MajorTopicYN="Y">Gene-Environment Interaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Inhibition of neuregulin-mediated inflammation</Keyword><Keyword MajorTopicYN="N">Nerve injury-mediated neuroinflammation</Keyword><Keyword MajorTopicYN="N">Neuronal-glial communication through glial growth factor neuregulin</Keyword></KeywordList><CoiStatement>The authors (JAL and FS) have intellectual property on the use of the neuregulin antagonist fusion protein to treat neurodegenerative diseases.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32505190</ArticleId><ArticleId IdType="pmc">PMC7276078</ArticleId><ArticleId IdType="doi">10.1186/s12974-020-01849-7</ArticleId><ArticleId IdType="pii">10.1186/s12974-020-01849-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen S, Sayana P, Zhang X, Lecorresponding W. Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener. 2013;8:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3766231</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, Harati Y, Mitsumoto H, Pascuzzi R, Spencer PS, Tim R, Howard D, Smith TC, Ryan MAK, Coffman CJ, Kasarskis EJ. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003;61:742&#x2013;749.</Citation><ArticleIdList><ArticleId IdType="pubmed">14504315</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser AE, Rooney JPK, D&#x2019;Ovidio F, Westeneng HJ, Vermeulen RCH, Beghi E, Chio A, Logroscino G, Hardiman O, Veldink JH, van den Berg LH. Euro-MOTOR consortium: Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2018;89:797&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pubmed">29685899</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B, Horton DK, Mitsumoto H. Potential environmental factors in amyotrophic lateral sclerosis. Neurol Clin. 2015;33:877&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4646848</ArticleId><ArticleId IdType="pubmed">26515627</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarneas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and varsity athletics in ALS. Neurology. 2002;59:773&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pubmed">12221178</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A. Mortality trends in ALS: an increasingly intricate puzzle. Lancet Neurol. 2005;4:453&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">16033687</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidetti D, Bondavalli M, Sabadini R, Marcello N, Vinceti M, Cavalletti S, Marbini A, Gemignani F, Colombo A, Ferrari A, Vivoli G, Solim&#xe8; F. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: influence of environmental exposure to lead. Neuroepidemiology. 1996;15:301&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pubmed">8930943</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaglehouse YL, Talbott EO, Chang Y, Kuller LH. Participation in physical activity and risk for amyotrophic lateral sclerosis mortality among postmenopausal women. JAMA Neurol. 2016;73:329&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6044440</ArticleId><ArticleId IdType="pubmed">26783702</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Richard M, Sandler DP, Umbach DM, Kamel F. Head injury and amyotrophic lateral sclerosis. Am J Epidemiol. 2007;166:810&#x2013;816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2239342</ArticleId><ArticleId IdType="pubmed">17641152</ArticleId></ArticleIdList></Reference><Reference><Citation>Moszczynski AJ, Strong W, Xu K, McKee A, Brown A, Strong MJ. Pathologic Thr175tau phosphorylation in CTE and CTE with ALS. Neurology. 2018;90:380&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo V, Vanacore N, Bueno-de-Mesquita HB, Vermeulen R, Brayne C, Pearce N, Wark PA, Ward HA, Ferrari P, Jenab M, Andersen PM, Wennberg P, Wareham N, Katzke V, Kaaks R, Weiderpass E, Peeters PH, Mattiello A, Pala V, Barricante A, Chirlaque MD, Travier N, Travis RC, Sanchez MJ, Pessah-Rasmussen H, Petersson J, Tj&#xf8;nneland A, Tumino R, Quiros JR, Trichopoulou A, Kyrozis A, Oikonomidou D, Masala G, Sacerdote C, Arriola L, Boeing H, Vigl M, Claver-Chapelon F, Middleton L, Riboli E, Vineis P. Physical activity and risk of amyotrophic lateral sclerosis in a prospective cohort study. Eur J Epidemiol. 2016;31:255&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4820490</ArticleId><ArticleId IdType="pubmed">26968841</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo E, Messina P, Giussani G, Logroscino G, Zoccolella S, Chi&#xf2; A, Calvo A, Corbo M, Lunetta C, Marin B, Mitchell D, Hardiman O, Rooney J, Stevic Z, Bandettini di Poggio M, Filosto M, Cotelli MS, Perini M, Riva N, Tremolizzo L, Vitelli E, Damiani D, Beghi E: EURALS Consortium. Physical activity and amyotrophic lateral sclerosis: a European population-based case-control study. Ann Neurol 2014:75:708-716.</Citation><ArticleIdList><ArticleId IdType="pubmed">24706338</ArticleId></ArticleIdList></Reference><Reference><Citation>Seals RM, Hansen J, Gredal O, Weisskopf MG. Physical trauma and amyotrophic lateral sclerosis: a population-based study using Danish National Registries. Am J Epidemiol. 2016;183:294&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4753279</ArticleId><ArticleId IdType="pubmed">26825926</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp PS, Dick JR, Greensmith L. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neuroscience. 2005;130:897&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pubmed">15652988</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariotti R, Cristino L, Bressan C, Boscolo S, Bentivoglio M. Altered reaction of facial motoneurons to axonal damage in the presymptomatic phase of a murine model of familial amyotrophic lateral sclerosis. Neuroscience. 2002;115:331&#x2013;335.</Citation><ArticleIdList><ArticleId IdType="pubmed">12421599</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff TM, Costantini KJ, Crane JW, Atkin JD, Monk PN, Taylor SM, Noakes PG. The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis. J Immunol. 2008;181:8727&#x2013;8734.</Citation><ArticleIdList><ArticleId IdType="pubmed">19050293</ArticleId></ArticleIdList></Reference><Reference><Citation>Schram S, Chuang D, Schmidt G, Piponov H, Helder C, Kerns J, Gonzalez M, Song F, Loeb JA. Mutant SOD1 prevents normal functional recovery through enhanced glial activation and loss of motor neuron innervation after peripheral nerve injury. Neurobiol Dis. 2019;124:469&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pubmed">30594811</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepore AC, Tolmie C, O'Donnell J, Wright MC, Dejea C, Rauck B, Hoke A, Ignagni AR, Onders RP, Maragakis NJ. Peripheral hyperstimulation alters site of disease onset and course in SOD1 rats. Neurobiol Dis. 2010;39:252&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2910141</ArticleId><ArticleId IdType="pubmed">20381620</ArticleId></ArticleIdList></Reference><Reference><Citation>Franz CK, Quach ET, Krudy CA, Federici T, Kliem MA. A conditioning lesion provides selective protection in a rat model of amyotrophic lateral sclerosis. PLoS ONE. 2009;4:e7357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2752158</ArticleId><ArticleId IdType="pubmed">19806196</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J, Xu Z. Peripheral axotomy slows motoneuron degeneration in a transgenic mouse line expressing mutant SOD1 G93A. J Comp Neurol. 1999;412:373&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pubmed">10441762</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadani SP, Walsh JT, Lukens JR, Kipnis J. Dealing with danger in the CNS: the response of the immune system to injury. Neuron. 2015;87:47&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4491143</ArticleId><ArticleId IdType="pubmed">26139369</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Dissing-Olesen L, MacVicar BA, Stevens B. Microglia: dynamic mediators of synapse development and plasticity. Trends Immunol. 2015;36:605&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4841266</ArticleId><ArticleId IdType="pubmed">26431938</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierra A, Encinas JM, Deudero JJ, et al. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell. 2010;7:483&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4008496</ArticleId><ArticleId IdType="pubmed">20887954</ArticleId></ArticleIdList></Reference><Reference><Citation>Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci. 2009;29:3974&#x2013;3980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6665392</ArticleId><ArticleId IdType="pubmed">19339593</ArticleId></ArticleIdList></Reference><Reference><Citation>Blinzinger K, Krautzberg G. Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Z Zellforsch Mikrosk Anat. 1968;85:145&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">5706753</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada J, Jinno S. Alterations in neuronal survival and glial reactions after axotomy by ceftriaxone and minocycline in the mouse hypoglossal nucleus. Neurosci Lett. 2011;504:295&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">21970974</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, Lemere CA, Selkoe DJ, Stevens B. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712&#x2013;716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5094372</ArticleId><ArticleId IdType="pubmed">27033548</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, Sher A, Litke AM, Lambris JD, Smith SJ, John SW, Barres BA. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131:1164&#x2013;1178.</Citation><ArticleIdList><ArticleId IdType="pubmed">18083105</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravel M, B&#xe9;land LC, Soucy G, Abdelhamid E, Rahimian R, Gravel C, Kriz J. IL-10 controls early microglial phenotypes and disease onset in ALS caused by misfolded superoxide dismutase 1. J Neurosci. 2016;36:1031&#x2013;1048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6601999</ArticleId><ArticleId IdType="pubmed">26791230</ArticleId></ArticleIdList></Reference><Reference><Citation>Geloso MC, Corvino V, Marchese E, Serrano A, Michetti F, D'Ambrosi N. The dual role of microglia in ALS: mechanisms and therapeutic approaches. Front Aging Neurosci. 2017;9:242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5524666</ArticleId><ArticleId IdType="pubmed">28790913</ArticleId></ArticleIdList></Reference><Reference><Citation>Brites D, Vaz AR. Microglia centered pathogenesis in ALS: insights in cell interconnectivity. Front Cell Neurosci. 2014;8:117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4033073</ArticleId><ArticleId IdType="pubmed">24904276</ArticleId></ArticleIdList></Reference><Reference><Citation>Sargsyan SA, Blackburn DJ, Barber SC, Monk PN, Shaw PJ. Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1. Neuroreport. 2009;20:1450&#x2013;1455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2889291</ArticleId><ArticleId IdType="pubmed">19752764</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikodemova M, Small AL, Smith SM, Mitchell GS, Watters JJ. Spinal but not cortical microglia acquire an atypical phenotype with high VEGF, galectin-&#xad;3 and osteopontin, and blunted inflammatory responses in ALS rats. Neurobiol Dis. 2014;69:43&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4079765</ArticleId><ArticleId IdType="pubmed">24269728</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312(5778):1389&#x2013;1392.</Citation><ArticleIdList><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Deng HX, Grisotti G, Zhai H, Siddique T, Roos RP. Wildtype SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse. Hum Mol Genet. 2009;18:1642&#x2013;1651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2667291</ArticleId><ArticleId IdType="pubmed">19233858</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, et al. Wildtype microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2006;103:16021&#x2013;16026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Bell S, Wang J, Wen S, Baloh RH, Appel SH. TDP-43 activates microglia through NF-&#x3ba;B and NLRP3 inflammasome. Exp Neurol. 2015;273:24&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">26222336</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ambrosi N, Finocchi P, Apolloni S, Cozzolino M, Ferri A, Padovano V, Pietrini G, Carr&#xec; MT, Volont&#xe9; C. The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis. J Immunol. 2009;183:4648&#x2013;4656.</Citation><ArticleIdList><ArticleId IdType="pubmed">19734218</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes AE, Ferraiuolo L, Haidet-Phillips AM, et al. Microglia induce motor neuron death via the classical NF-&#xad;&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Song F, Chiang P, Ravits J, Loeb JA. Activation of microglial neuregulin1 signaling in the corticospinal tracts of ALS patients with upper motor neuron signs. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:77&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">24229388</ArticleId></ArticleIdList></Reference><Reference><Citation>Song F, Chiang P, Wang J, Ravits J, Loeb JA. Aberrant neuregulin 1 signaling in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2012;71:104&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3270561</ArticleId><ArticleId IdType="pubmed">22249457</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, Leigh PN, Banati RB. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis. 2004;15:601&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM, Morimoto ET, Goodarzi H, Liao JT, O'Keeffe S, Phatnani HP, Muratet M, Carroll MC, Levy S, Tavazoie S, Myers RM, Maniatis T. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013;4:385&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Falls DL, Rosen KM, Corfas G, Lane WS, Fischbach GD. ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family. Cell. 1993;72:801&#x2013;815.</Citation><ArticleIdList><ArticleId IdType="pubmed">8453670</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho WH, Armanini MP, Nuijens A, Phillips HS, Osheroff PL. Sensory and motor neuron-derived factor. A novel heregulin variant highly expressed in sensory and motor neurons. J Biol Chem. 1995;270:26722.</Citation><ArticleIdList><ArticleId IdType="pubmed">7592900</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodearl AD, Davis JB, Mistry K, Minghetti L, Otsu M, Waterfield MD, Stroobant P. Purification of multiple forms of glial growth factor. J Biol Chem. 1993;268:18095&#x2013;18102.</Citation><ArticleIdList><ArticleId IdType="pubmed">8394360</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchionni MA, Goodearl ADJ, Chen MS, Bermingham-McDonough O, Kirk C, Hendricks M, Denehy F, Misumi D, Sudhalter J, Kobayashi K, Wroblewski D, Lynch C, Baldassare M, Hiles I, Davis JB, Hsuan JJ, Totty WF, Otsa M, McBury RN, Waterfield MD, Stroobant P. Gwynne D: Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature. 1993;362:312&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">8096067</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen D, Peles E, Cupples R, Suggs SV, Bacus SS, Lup Y, Trail G, Hu S, Silbiger SM, Levy RB, Koski RA, Lu HS, Yarden Y. Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell. 1992;69:P559&#x2013;P572.</Citation><ArticleIdList><ArticleId IdType="pubmed">1349853</ArticleId></ArticleIdList></Reference><Reference><Citation>Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB, Yarden Y. Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell. 1992;69:205&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">1348215</ArticleId></ArticleIdList></Reference><Reference><Citation>Falls DL. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res. 2003;284:14&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">12648463</ArticleId></ArticleIdList></Reference><Reference><Citation>Esper RM, Pankonin MS, Loeb JA. Neuregulins: versatile growth and differentiation factors in nervous system development and human disease. Brain Res Rev. 2006;51:161&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">16412517</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei L, Nave KA. Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases. Neuron. 2014;83:27&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4189115</ArticleId><ArticleId IdType="pubmed">24991953</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei L, Xiong WC. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci. 2008;9:437&#x2013;452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2682371</ArticleId><ArticleId IdType="pubmed">18478032</ArticleId></ArticleIdList></Reference><Reference><Citation>Fricker FR, Bennett DL. The role of neuregulin&#xad;1 in the response to nerve injury. Future Neurol. 2011;6:809&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3223410</ArticleId><ArticleId IdType="pubmed">22121335</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon YK, Bhattacharyya A, Alberta JA, Giannobile WV, Cheon K, Stiles CD, Pomeroy SL. Activation of ErbB2 during Wallerian degeneration of sciatic nerve. J Neurosci. 1997;17:8293&#x2013;8299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573732</ArticleId><ArticleId IdType="pubmed">9334404</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll SL1, Miller ML, Frohnert PW, Kim SS, Corbett JA. Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration. J Neurosci. 1997;17:1642&#x2013;1659.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573392</ArticleId><ArticleId IdType="pubmed">9030624</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartus K, Galino J, James ND, Hernandez-Miranda LR, Dawes JM, Fricker FR, Garratt AN, McMahon SB, Ramer MS, Birchmeier C, Bennett DL, Bradbury EJ. Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury. Brain. 2016;139(Pt 5):1394&#x2013;1416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5477508</ArticleId><ArticleId IdType="pubmed">26993800</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo M, Zhu N, Tsantoulas C, Ma Z, Grist J, Loeb JA, Bennett DL. Neuregulin-ErbB signaling promotes microglial proliferation and chemotaxis contributing to microgliosis and pain after peripheral nerve injury. J Neurosci. 2010;30:5437&#x2013;5450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2862659</ArticleId><ArticleId IdType="pubmed">20392965</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo M, Zhu N, Tsantoulas C, Ma Z, Grist J, Loeb JA, Bennett DL. Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway. Glia. 2011;59:554&#x2013;568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3222694</ArticleId><ArticleId IdType="pubmed">21319222</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Allender E, Wang J, Simpson EH, Loeb JA, Song F. Slowing disease progression in the SOD1 mouse model by blocking neuregulin-induced microglial activation. Neurobiol Dis. 2018;111:118&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">29278738</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y, Fukuda Y, Yoshimura J, et al. ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19. Am J Hum Genet. 2013;93:900&#x2013;905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3824132</ArticleId><ArticleId IdType="pubmed">24119685</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour D, Vande Velde C, Robitaille R. New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction. J Physiol. 2017;595:647&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5285712</ArticleId><ArticleId IdType="pubmed">27633977</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z, Li Q, An H, Pankonin MS, Wang J, Loeb JA. Targeting human epidermal growth factor receptor signaling with the neuregulin's heparin-binding domain. J Biol Chem. 2009;284:32108&#x2013;32115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2797281</ArticleId><ArticleId IdType="pubmed">19717564</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasiene J, Komine O, Fujimori-Tonou N, Powers B, Endo F, Watanabe S, Shijie J, Ravits J, Horner P, Misawa H, Yamanaka K. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons. Acta Neuropathologica Communications. 2016;4:15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4758105</ArticleId><ArticleId IdType="pubmed">26891847</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallart-Palau X, Tarabal O, Casanovas A, Sabado J, Correa FJ, Hereu M, Piedrafita L, Caldero J, Esquerda JE. Neuregulin-1 is concentrated in the postsynaptic subsurface cistern of C-bouton inputs to alpha-motoneurons and altered during motoneuron diseases. FASEB J. 2014;28:618&#x2013;3632.</Citation><ArticleIdList><ArticleId IdType="pubmed">24803543</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R, Martinez-Muriana A, Leiva T, Gregorio D, Ariza L, Morell M, Esteban-Perez J, Garcia-Redondo A, Calvo AC, Atencia-Cibreiro G, Corfas G, Osta R, Bosch A, Navarro X. Neuregulin-1 promotes functional improvement by enhancing collateral sprouting in SOD1(G93A) ALS mice and after partial muscle denervation. Neurobiol Dis. 2016;95:168&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">27461051</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf2;dol-Caballero G, Garc&#xed;a-Lareu B, Verd&#xe9;s S, Ariza L, S&#xe1;nchez-Brualla I, Brocard F, Bosch A, Navarro X, Herrando-Grabulosa M. Therapeutic role of neuregulin 1 type III in SOD1-linked amyotrophic lateral sclerosis. Neurotherapeutics. 2020.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>